Aptus Capital Advisors »

Eupraxia Pharmaceuticals shares owned by Aptus Capital Advisors

Quarter-by-quarter ownership of Eupraxia Pharmaceuticals (EPRX) shares owned by Aptus Capital Advisors from 13F filings

Historical chart of Aptus Capital Advisors investment in Eupraxia Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Eupraxia Pharmaceuticals held by Aptus Capital Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Eupraxia Pharmaceuticals by Aptus Capital Advisors

Quarter filed Position value Share count Share price at filing
2025-12-31 $76k 10k 7.55

More positions owned by Aptus Capital Advisors

Ishares Tr Iboxx Hi Yd Etf (HYG)
Etf Ser Solutions Aptus Collrd Inv (ACIO)
Select Sector Spdr Tr State Street Fin (XLF)
Etf Ser Solutions Aptus Defined (DRSK)
Vanguard Star Fds Vg Tl Intl Stk F (VXUS)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Invesco Qqq Tr Unit Ser 1 (QQQ)
salesforce (CRM)
Etf Ser Solutions Opus Sml Cp Vl (OSCV)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Merck & Co (MRK)
Invesco Exch Trd Slf Idx Bulletshs 2032 (BSCW)
Invesco Exch Trd Slf Idx Buletshs 2031 Cp (BSCV)

View all positions for Aptus Capital Advisors

Top funds holding Eupraxia Pharmaceuticals

Beutel, Goodman & Company
Vivo Capital
Balyasny Asset Management
Scotia Capital
Dr. Jeffrey R. Jay, M.D.
Point72 Asset Management
Ikarian Capital
Royal Bank of Canada
Ally Bridge Group
Velan Capital Investment Management
Affinity Asset Advisors
Arrowstreet Capital, Limited Partnership
UBS Group
SummitTX Capital
Marshall Wace

View all funds holding Eupraxia Pharmaceuticals